中华劳动卫生职业病杂志
中華勞動衛生職業病雜誌
중화노동위생직업병잡지
CHINESE JOURNAL OF INDUSTRIAL HYGIENE AND OCCUPATIONAL DISEASES
2011年
10期
740-745
,共6页
翁泽平%张继君%刘薇薇%陈娟%刘移民%余卫%唐丽娟%陈嘉榆%方茅%张程%叶更新%陈玲珍%钟雪云
翁澤平%張繼君%劉薇薇%陳娟%劉移民%餘衛%唐麗娟%陳嘉榆%方茅%張程%葉更新%陳玲珍%鐘雪雲
옹택평%장계군%류미미%진연%류이민%여위%당려연%진가유%방모%장정%협경신%진령진%종설운
肝细胞生长因子%髓样组细胞%肺纤维化%羟脯氨酸
肝細胞生長因子%髓樣組細胞%肺纖維化%羥脯氨痠
간세포생장인자%수양조세포%폐섬유화%간포안산
Hepatocyte growth factor%Myeloid progenitor cells%Pulmonary fibrosis%Hydroxyproline
目的 比较骨髓间充质样干细胞( BM-MSCs)与pcDNA3.1肝细胞生长因子(HGF)转染的BM-MSCs对SiO2所致大鼠肺泡炎和早期肺纤维化的影响并探讨其机制.方法 收集培养雄性Wistar 幼鼠的原代BM-MSCs,并进行4,6-联脒-2-苯基吲哚(DAPI)标记.将50只雄性Wistar大鼠气管滴注40mg/ml SiO2混悬液1ml造模后,随机分为模型组、BM-MSCs组和pcDNA 3.1-HGF+BM-MSCs组.造模次日,模型组(10只):尾静脉注入PBS 1 ml; BM-MSCs组(20只):尾静脉注入106个/ml BM-MSCs 1 ml;pcD-NA3.1-HGF+BM-MSCs组(20只):尾静脉注入106个/ml pcDNA3.1-HGF转染的BM-MSCs 1 ml.14和28 d后,分别处死大鼠,取肺组织冰冻切片,荧光显微镜下检测体内DAPI标记细胞;HE和Masson染色观察肺炮炎和纤维化情况;免疫印迹( Western blot)法测各组大鼠肺组织的HGF表达量;ELISA法检测肺组织中肿瘤坏死因子(TNF)-α的含量,样本碱水解法检测肺组织中羟脯氨酸(HYP)的含量.结果14、28 d时,pcDNA3.1-HGF+BM-MSCs组肺组织肺泡炎评分(14 d:1.16±0.13,28 d:0.82±0.20)均低于同时期BM-MSCs组(14 d:1.68±0.17,28 d:1.58±0.31)和模型组(14 d:2.36±0.17,28 d:2.80±0.14),BM-MSCs组肺泡炎评分均低于同时期模型组,差异均有统计学意义(P<0.05).14、28 d时pcDNA3.1-HGF+BM-MSCs组肺纤维化评分( 14 d:0.10±0.11,28 d:1.16±0.13)均明显低于同时期BM-MSCs( 14 d:0.54±0.15,28 d:1.36±0.13)和模型组(14 d:0.64±0.09,28 d:1.84±0.17),差异均有统计学意义(P<0.05).14、28 d时pcDNA3.1-HGF+BM-MSCs组肺组织匀浆中TNF-α含量[14 d:(280.48±23.11) pg/mg,28 d:(249.78±22.33) pg/mg]均明显低于BM-MSCs组[14 d:(342.58±35.34) pg/mg,28 d:(319.51±17.84) pg/mg]和模型组[14 d:(442.29±36.76) pg/mg,28 d:(348.53±33.95) pg/mg],BM-MSCs组肺组织匀浆中TNF-α含量低于模型组,差异均有统计学意义(P<0.05).14、28 d时pcDNA3.1-HGF+BM-MSCs组肺组织匀浆中HYP表达量[14 d:(0.46±0.04) μg/mg,28 d:(0.65±0.05)μg/mg]均明显低于同时期BM-MSCs组[14 d:(0.63±0.04) μg/mg,28 d:(1.04±0.07) μg/mg]和模型组[14 d:(0.72±0.06) μg/mg,28 d:(1.39±0.06) μg/mg],差异均有统计学意义(P<0.05);28 d时,BM-MSCs组肺组织匀浆中HYP表达量低于模型组,差异有统计学意义(P<0.05).结论 应用pcDNA3.1-HGF转染后的BM-MSCs比单独应用BM-MSCs能更有效地对抗SiO2诱导的大鼠肺泡炎和早期肺纤维化,作用机制可能与其减轻肺组织的炎症有关.
目的 比較骨髓間充質樣榦細胞( BM-MSCs)與pcDNA3.1肝細胞生長因子(HGF)轉染的BM-MSCs對SiO2所緻大鼠肺泡炎和早期肺纖維化的影響併探討其機製.方法 收集培養雄性Wistar 幼鼠的原代BM-MSCs,併進行4,6-聯脒-2-苯基吲哚(DAPI)標記.將50隻雄性Wistar大鼠氣管滴註40mg/ml SiO2混懸液1ml造模後,隨機分為模型組、BM-MSCs組和pcDNA 3.1-HGF+BM-MSCs組.造模次日,模型組(10隻):尾靜脈註入PBS 1 ml; BM-MSCs組(20隻):尾靜脈註入106箇/ml BM-MSCs 1 ml;pcD-NA3.1-HGF+BM-MSCs組(20隻):尾靜脈註入106箇/ml pcDNA3.1-HGF轉染的BM-MSCs 1 ml.14和28 d後,分彆處死大鼠,取肺組織冰凍切片,熒光顯微鏡下檢測體內DAPI標記細胞;HE和Masson染色觀察肺砲炎和纖維化情況;免疫印跡( Western blot)法測各組大鼠肺組織的HGF錶達量;ELISA法檢測肺組織中腫瘤壞死因子(TNF)-α的含量,樣本堿水解法檢測肺組織中羥脯氨痠(HYP)的含量.結果14、28 d時,pcDNA3.1-HGF+BM-MSCs組肺組織肺泡炎評分(14 d:1.16±0.13,28 d:0.82±0.20)均低于同時期BM-MSCs組(14 d:1.68±0.17,28 d:1.58±0.31)和模型組(14 d:2.36±0.17,28 d:2.80±0.14),BM-MSCs組肺泡炎評分均低于同時期模型組,差異均有統計學意義(P<0.05).14、28 d時pcDNA3.1-HGF+BM-MSCs組肺纖維化評分( 14 d:0.10±0.11,28 d:1.16±0.13)均明顯低于同時期BM-MSCs( 14 d:0.54±0.15,28 d:1.36±0.13)和模型組(14 d:0.64±0.09,28 d:1.84±0.17),差異均有統計學意義(P<0.05).14、28 d時pcDNA3.1-HGF+BM-MSCs組肺組織勻漿中TNF-α含量[14 d:(280.48±23.11) pg/mg,28 d:(249.78±22.33) pg/mg]均明顯低于BM-MSCs組[14 d:(342.58±35.34) pg/mg,28 d:(319.51±17.84) pg/mg]和模型組[14 d:(442.29±36.76) pg/mg,28 d:(348.53±33.95) pg/mg],BM-MSCs組肺組織勻漿中TNF-α含量低于模型組,差異均有統計學意義(P<0.05).14、28 d時pcDNA3.1-HGF+BM-MSCs組肺組織勻漿中HYP錶達量[14 d:(0.46±0.04) μg/mg,28 d:(0.65±0.05)μg/mg]均明顯低于同時期BM-MSCs組[14 d:(0.63±0.04) μg/mg,28 d:(1.04±0.07) μg/mg]和模型組[14 d:(0.72±0.06) μg/mg,28 d:(1.39±0.06) μg/mg],差異均有統計學意義(P<0.05);28 d時,BM-MSCs組肺組織勻漿中HYP錶達量低于模型組,差異有統計學意義(P<0.05).結論 應用pcDNA3.1-HGF轉染後的BM-MSCs比單獨應用BM-MSCs能更有效地對抗SiO2誘導的大鼠肺泡炎和早期肺纖維化,作用機製可能與其減輕肺組織的炎癥有關.
목적 비교골수간충질양간세포( BM-MSCs)여pcDNA3.1간세포생장인자(HGF)전염적BM-MSCs대SiO2소치대서폐포염화조기폐섬유화적영향병탐토기궤제.방법 수집배양웅성Wistar 유서적원대BM-MSCs,병진행4,6-련미-2-분기신타(DAPI)표기.장50지웅성Wistar대서기관적주40mg/ml SiO2혼현액1ml조모후,수궤분위모형조、BM-MSCs조화pcDNA 3.1-HGF+BM-MSCs조.조모차일,모형조(10지):미정맥주입PBS 1 ml; BM-MSCs조(20지):미정맥주입106개/ml BM-MSCs 1 ml;pcD-NA3.1-HGF+BM-MSCs조(20지):미정맥주입106개/ml pcDNA3.1-HGF전염적BM-MSCs 1 ml.14화28 d후,분별처사대서,취폐조직빙동절편,형광현미경하검측체내DAPI표기세포;HE화Masson염색관찰폐포염화섬유화정황;면역인적( Western blot)법측각조대서폐조직적HGF표체량;ELISA법검측폐조직중종류배사인자(TNF)-α적함량,양본감수해법검측폐조직중간포안산(HYP)적함량.결과14、28 d시,pcDNA3.1-HGF+BM-MSCs조폐조직폐포염평분(14 d:1.16±0.13,28 d:0.82±0.20)균저우동시기BM-MSCs조(14 d:1.68±0.17,28 d:1.58±0.31)화모형조(14 d:2.36±0.17,28 d:2.80±0.14),BM-MSCs조폐포염평분균저우동시기모형조,차이균유통계학의의(P<0.05).14、28 d시pcDNA3.1-HGF+BM-MSCs조폐섬유화평분( 14 d:0.10±0.11,28 d:1.16±0.13)균명현저우동시기BM-MSCs( 14 d:0.54±0.15,28 d:1.36±0.13)화모형조(14 d:0.64±0.09,28 d:1.84±0.17),차이균유통계학의의(P<0.05).14、28 d시pcDNA3.1-HGF+BM-MSCs조폐조직균장중TNF-α함량[14 d:(280.48±23.11) pg/mg,28 d:(249.78±22.33) pg/mg]균명현저우BM-MSCs조[14 d:(342.58±35.34) pg/mg,28 d:(319.51±17.84) pg/mg]화모형조[14 d:(442.29±36.76) pg/mg,28 d:(348.53±33.95) pg/mg],BM-MSCs조폐조직균장중TNF-α함량저우모형조,차이균유통계학의의(P<0.05).14、28 d시pcDNA3.1-HGF+BM-MSCs조폐조직균장중HYP표체량[14 d:(0.46±0.04) μg/mg,28 d:(0.65±0.05)μg/mg]균명현저우동시기BM-MSCs조[14 d:(0.63±0.04) μg/mg,28 d:(1.04±0.07) μg/mg]화모형조[14 d:(0.72±0.06) μg/mg,28 d:(1.39±0.06) μg/mg],차이균유통계학의의(P<0.05);28 d시,BM-MSCs조폐조직균장중HYP표체량저우모형조,차이유통계학의의(P<0.05).결론 응용pcDNA3.1-HGF전염후적BM-MSCs비단독응용BM-MSCs능경유효지대항SiO2유도적대서폐포염화조기폐섬유화,작용궤제가능여기감경폐조직적염증유관.
Objective To compare the difference of effects on SiO2-induced alveolitis and early fibrosis between bone marrow-derived mesenchymal-like stem cells (BM-MSCs) and BM-MSCs transfected by pcD-NA3.1-HGF and to explore the mechanism of this effects.Methods The Primary BM-MSCs from Wistar male young rats were cultured and labeled by 4,6-diamidino-2-phenylindole (DAPI).Fifty Wistar rats were randomly divided into 3 groups:model group ( 10 rats),which was administered with SiO2 by the trache,the next day,injected PBS via the tail vein; BM-MSCs group (20 rats),which was administered with SiO2 by the trache,the next day,injected with 1 ml suspension of BM-MSCs via the tail vein; PcDNA3.1-HGF plus BM-MSC group (20 rats),which was administered with SiO2 by the trache,the next day,injected with 1 ml suspension of BM-MSCs transfected by pcDNA3.1-HGF via the tail vein.On the 14th and 28th days after treatment,half of the animals were sacrificed,respectively,and the lungs were harvested for frozen section to observe the cell marked by DAP1.HE staining under a fluorescent microscope,and to observe the pulmonary alveolitis and fibrosis by HE and Masson staining under a light microscope.Western blot assay was used to detect the expression of HGF in rat lungs.The expression levels of tumor necrosis factor-α (TNF-α) in pulmonary tissues were analyzed quantitatively by ELISA.The contents of HYP in pulmonary tissues were analyzed quantitatively by sample hydrolysis method.Results On the 14th and 28th days after treatment,the scores of pulmonary alveolitis and early fibrosis in pcDNA3.1-HGF plus BM-MSCs group were 2.36±0.17,2.8±0.14 and 0.14-0.11,1.16±0.13,which were significantly lower than those ( 1.68±0.17,1.58±0.31 and 0.54±0.15,1.36±0.13) in BM-MSCs group,also which were significantly lower those (2.36±0.17,2.80±0.14 and 0.64±0.09,1.84±0.17) in model group (P<0.05); On the 14th and 28th days after treatment,the TNF-α contents of pulmonary tissues in pcDNA3.1-HGF plus BM-MSCs group were 280.4±23.11 and 249.78±22.33 pg/mg,which were significantly lower than those (341.58±35.34,442.29±36.76 pg/mg and 319.51±17.84,348.53±33.95 pg/mg) in BM-MSCs and model groups (P<0.05 ); On the 14th and 28th days after treatment,the HYP contents of pulmonary tissues in pcDNA3.1-HGF plus BM-MSCs group were 0.46±0.04 and 0.65±0.05 μg/mg,which were significantly lower than those (0.63±0.04,1.04±0.07μg/mg and 0.72±0.60,1.39±0.60μg/mg) in BM-MSCs and model groups (P<0.05).Conclusion The effects of BM-MSCs transfected by pcDNA3.1-HGF on suppressing pulmonary alveolitis and early fibrosis induced by SiO2 were better than those of BM-MSCs.The mechanism may be associated with the reduced pulmonary inflammation.